Sweden
· Delayed Price · Currency is SEK Egetis Therapeutics AB Statistics
Total Valuation
STO:EGTX has a market cap or net worth of SEK 1.31 billion. The enterprise value is 1.07 billion.
| Market Cap | 1.31B |
| Enterprise Value | 1.07B |
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:EGTX has 359.24 million shares outstanding. The number of shares has increased by 19.57% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 359.24M |
| Shares Change (YoY) | +19.57% |
| Shares Change (QoQ) | +18.69% |
| Owned by Insiders (%) | 13.32% |
| Owned by Institutions (%) | 18.33% |
| Float | 210.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.27 |
| PB Ratio | 2.66 |
| P/TBV Ratio | 2.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.13 |
| EV / Sales | 23.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.86 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.72 |
Financial Efficiency
Return on equity (ROE) is -66.17% and return on invested capital (ROIC) is -32.52%.
| Return on Equity (ROE) | -66.17% |
| Return on Assets (ROA) | -26.52% |
| Return on Invested Capital (ROIC) | -32.52% |
| Return on Capital Employed (ROCE) | -56.01% |
| Revenue Per Employee | 1.15M |
| Profits Per Employee | -8.59M |
| Employee Count | 40 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 13.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.70% in the last 52 weeks. The beta is 1.25, so STO:EGTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | -44.70% |
| 50-Day Moving Average | 5.02 |
| 200-Day Moving Average | 5.40 |
| Relative Strength Index (RSI) | 23.59 |
| Average Volume (20 Days) | 476,437 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:EGTX had revenue of SEK 46.10 million and -343.60 million in losses. Loss per share was -1.12.
| Revenue | 46.10M |
| Gross Profit | 34.50M |
| Operating Income | -329.40M |
| Pretax Income | -343.30M |
| Net Income | -343.60M |
| EBITDA | -325.80M |
| EBIT | -329.40M |
| Loss Per Share | -1.12 |
Balance Sheet
The company has 351.00 million in cash and 114.60 million in debt, giving a net cash position of 236.40 million or 0.66 per share.
| Cash & Cash Equivalents | 351.00M |
| Total Debt | 114.60M |
| Net Cash | 236.40M |
| Net Cash Per Share | 0.66 |
| Equity (Book Value) | 492.90M |
| Book Value Per Share | 1.37 |
| Working Capital | 175.90M |
Cash Flow
| Operating Cash Flow | -227.90M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 74.84% |
| Operating Margin | -714.53% |
| Pretax Margin | -744.69% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:EGTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.57% |
| Shareholder Yield | -19.57% |
| Earnings Yield | -26.20% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STO:EGTX has an Altman Z-Score of -0.27. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.27 |
| Piotroski F-Score | n/a |